Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy
=======================================================================================================================================================

* Ghayathri Jeyakumar
* Seongho Kim
* Naresh Bumma
* Craig Landry
* Cynthia Silski
* Stacey Suisham
* Brenda Dickow
* Elisabeth Heath
* Joseph Fontana
* Ulka Vaishampayan